Setrusumab vs Placebo for Osteogenesis Imperfecta

NCT05125809 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

BIOLOGICAL: Setrusumab
OTHER: Placebo

Sponsor

Ultragenyx Pharmaceutical Inc

Collaborators

[object Object]